Cantitate/Preț
Produs

Drug Hepatotoxicity,An Issue of Clinics in Liver Disease: The Clinics: Internal Medicine, cartea 24-1

Editat de Pierre Gholam
en Limba Engleză Hardback – 20 noi 2019
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI).  Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.
Citește tot Restrânge

Din seria The Clinics: Internal Medicine

Preț: 45115 lei

Preț vechi: 57552 lei
-22% Nou

Puncte Express: 677

Preț estimativ în valută:
8635 89100$ 7188£

Carte tipărită la comandă

Livrare economică 28 decembrie 24 - 11 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323708579
ISBN-10: 0323708579
Pagini: 240
Dimensiuni: 152 x 229 mm
Greutate: 0.39 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine


Descriere

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI).  Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.